vs
Limoneira CO（LMNR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Limoneira CO的1.8倍（$75.5M vs $41.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -2.8%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.8%）
Limoneira是总部位于美国加利福尼亚州的领先农业企业，主营柑橘、牛油果等特色农产品的种植、加工与分销，产品销往北美、亚洲、欧洲等市场，服务零售及餐饮客户，同时布局可持续土地开发相关业务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LMNR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$41.3M
营收增速更快
PBYI
高出30.5%
-2.8%
两年增速更快
PBYI
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.3M | $75.5M |
| 净利润 | $-8.7M | — |
| 毛利率 | -15.1% | 69.3% |
| 营业利润率 | -26.8% | 22.7% |
| 净利率 | -21.0% | — |
| 营收同比 | -2.8% | 27.7% |
| 净利润同比 | -367.5% | — |
| 每股收益（稀释后） | $-0.49 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LMNRPBYI
| Q4 25 | $41.3M | $75.5M | ||
| Q3 25 | $45.9M | $54.5M | ||
| Q2 25 | $33.6M | $52.4M | ||
| Q1 25 | $32.9M | $46.0M | ||
| Q4 24 | $42.5M | $59.1M | ||
| Q3 24 | $61.8M | $80.5M | ||
| Q2 24 | $43.3M | $47.1M | ||
| Q1 24 | $38.3M | $43.8M |
净利润LMNRPBYI
| Q4 25 | $-8.7M | — | ||
| Q3 25 | $-855.0K | $8.8M | ||
| Q2 25 | $-3.4M | $5.9M | ||
| Q1 25 | $-3.1M | $3.0M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $6.6M | $20.3M | ||
| Q2 24 | $6.6M | $-4.5M | ||
| Q1 24 | $-3.6M | $-4.8M |
毛利率LMNRPBYI
| Q4 25 | -15.1% | 69.3% | ||
| Q3 25 | 8.5% | 77.7% | ||
| Q2 25 | 5.6% | 76.5% | ||
| Q1 25 | -2.0% | 77.1% | ||
| Q4 24 | 6.3% | 76.4% | ||
| Q3 24 | 26.5% | 63.9% | ||
| Q2 24 | 6.5% | 77.4% | ||
| Q1 24 | -2.0% | 75.5% |
营业利润率LMNRPBYI
| Q4 25 | -26.8% | 22.7% | ||
| Q3 25 | -1.4% | 17.6% | ||
| Q2 25 | -10.0% | 12.7% | ||
| Q1 25 | -16.3% | 8.7% | ||
| Q4 24 | -6.5% | 22.6% | ||
| Q3 24 | 14.5% | 27.4% | ||
| Q2 24 | -10.8% | -4.6% | ||
| Q1 24 | -20.2% | -5.3% |
净利率LMNRPBYI
| Q4 25 | -21.0% | — | ||
| Q3 25 | -1.9% | 16.2% | ||
| Q2 25 | -10.0% | 11.2% | ||
| Q1 25 | -9.4% | 6.5% | ||
| Q4 24 | -4.4% | — | ||
| Q3 24 | 10.7% | 25.2% | ||
| Q2 24 | 15.2% | -9.6% | ||
| Q1 24 | -9.4% | -11.0% |
每股收益（稀释后）LMNRPBYI
| Q4 25 | $-0.49 | $0.26 | ||
| Q3 25 | $-0.06 | $0.17 | ||
| Q2 25 | $-0.20 | $0.12 | ||
| Q1 25 | $-0.18 | $0.06 | ||
| Q4 24 | $-0.09 | $0.40 | ||
| Q3 24 | $0.35 | $0.41 | ||
| Q2 24 | $0.35 | $-0.09 | ||
| Q1 24 | $-0.21 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $72.5M | $22.7M |
| 股东权益账面价值 | $180.0M | $130.3M |
| 总资产 | $311.1M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.40× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LMNRPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务LMNRPBYI
| Q4 25 | $72.5M | $22.7M | ||
| Q3 25 | $63.4M | $34.0M | ||
| Q2 25 | $55.0M | $45.3M | ||
| Q1 25 | $58.0M | $56.7M | ||
| Q4 24 | $40.6M | $68.0M | ||
| Q3 24 | $40.6M | $79.3M | ||
| Q2 24 | $60.1M | $90.7M | ||
| Q1 24 | $52.1M | $102.0M |
股东权益LMNRPBYI
| Q4 25 | $180.0M | $130.3M | ||
| Q3 25 | $180.3M | $115.3M | ||
| Q2 25 | $182.7M | $104.7M | ||
| Q1 25 | $186.5M | $97.1M | ||
| Q4 24 | $191.7M | $92.1M | ||
| Q3 24 | $194.9M | $71.1M | ||
| Q2 24 | $189.0M | $48.5M | ||
| Q1 24 | $184.2M | $51.0M |
总资产LMNRPBYI
| Q4 25 | $311.1M | $216.3M | ||
| Q3 25 | $299.9M | $202.9M | ||
| Q2 25 | $296.6M | $194.9M | ||
| Q1 25 | $301.4M | $196.2M | ||
| Q4 24 | $298.8M | $213.3M | ||
| Q3 24 | $307.3M | $220.7M | ||
| Q2 24 | $322.2M | $205.0M | ||
| Q1 24 | $299.6M | $214.1M |
负债/权益比LMNRPBYI
| Q4 25 | 0.40× | 0.17× | ||
| Q3 25 | 0.35× | 0.30× | ||
| Q2 25 | 0.30× | 0.43× | ||
| Q1 25 | 0.31× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.21× | 1.12× | ||
| Q2 24 | 0.32× | 1.87× | ||
| Q1 24 | 0.28× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $942.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流LMNRPBYI
| Q4 25 | $942.0K | $14.4M | ||
| Q3 25 | $-3.0M | $9.7M | ||
| Q2 25 | $8.9M | $14.1M | ||
| Q1 25 | $-12.9M | $3.6M | ||
| Q4 24 | $6.6M | $15.6M | ||
| Q3 24 | $24.6M | $11.0M | ||
| Q2 24 | $-3.0M | $1.0M | ||
| Q1 24 | $-10.3M | $11.2M |
自由现金流LMNRPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率LMNRPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度LMNRPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率LMNRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.73× | 0.54× | ||
| Q2 24 | -0.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LMNR
| Lemon Packing | $33.9M | 82% |
| Other Agribusiness | $5.8M | 14% |
| Fresh Lemons | $1.3M | 3% |
PBYI
暂无分部数据
